Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Myasthenia Gravis Treatment Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population across the globe
5.1.1.2. Increasing cases of swollen eyes due to Myasthenia Gravis
5.1.1.3. Rising clinical trials for treatment
5.1.2. Restraints
5.1.2.1. High cost associated with the treatment
5.1.3. Opportunities
5.1.3.1. Improving healthcare infrastructure
5.1.3.2. Upsurge in the number of pipeline studies for drug development
5.1.4. Challenges
5.1.4.1. Side effects associated with drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Myasthenia Gravis Treatment Market, by Type
6.1. Introduction
6.2. Medication
6.3. Surgery

7. Myasthenia Gravis Treatment Market, by End-User
7.1. Introduction
7.2. Clinics
7.3. Hospitals

8. Americas Myasthenia Gravis Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Myasthenia Gravis Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Myasthenia Gravis Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Alexion Pharmaceutical Inc.
12.1.3. Argenx
12.1.4. Avadel Pharmaceuticals, PLC
12.1.5. Bausch Health Companies Inc.
12.1.6. Catalyst Pharmaceuticals Inc.
12.1.7. CSL Behring AG
12.1.8. F.Hoffmann-La Roche AG
12.1.9. GlaxoSmithKline PLC
12.1.10. Mitsubishi Tanabe Pharma Corporation
12.1.11. Pfizer, Inc.
12.1.12. Sandoz Inc. by Novartis AG
12.1.13. Sun Pharmaceuticals Industries
12.1.14. Taj Pharmaceuticals Ltd.
12.1.15. Takeda Pharmaceuticals Company Limited
12.1.16. Troikaa Pharmaceuticals Ltd.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. MYASTHENIA GRAVIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MYASTHENIA GRAVIS TREATMENT MARKET DYNAMICS
FIGURE 7. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. MYASTHENIA GRAVIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. MYASTHENIA GRAVIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. MYASTHENIA GRAVIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 9. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. CANADA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. CANADA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. MEXICO MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. MEXICO MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CHINA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CHINA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. INDIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. INDIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. JAPAN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. JAPAN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. THAILAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. THAILAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. DENMARK MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. EGYPT MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EGYPT MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. FINLAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. FINLAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. FRANCE MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. GERMANY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. GERMANY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ITALY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ITALY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. NORWAY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NORWAY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. POLAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. POLAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. QATAR MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. QATAR MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SPAIN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SPAIN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TURKEY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TURKEY MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MYASTHENIA GRAVIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. MYASTHENIA GRAVIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 98. MYASTHENIA GRAVIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 99. MYASTHENIA GRAVIS TREATMENT MARKET LICENSE & PRICING